21 CFR 1308.13 - Schedule III

Cite as21 CFR 1308.13
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
94 practice notes
  • Jana Marjenhoff, D.O.; Decision and Order
    • United States
    • Federal Register May 20, 2015
    • May 20, 2015
    ...\42\ Hydrocodone Bitartrate and Acetaminophen 10-500 mg is a Schedule III controlled substance. Stip. 5; 21 CFR 1308.13(e)(1)(iv). \43\ According to a key included in the PMP/Marjenhoff Report, the pharmacy identification number associated with this dispensing event corresponds to the numbe......
  • Registration revocations, restrictions, denials, reinstatements: Chein, Edmund, MD,
    • United States
    • Federal Register February 12, 2007
    • February 12, 2007
    ...and dispensed several controlled substances including testosterone in various formulations, a Schedule III anabolic steroid (see 21 CFR 1308.13(f)), and phentermine, a Schedule IV stimulant. See 21 CFR 1308.14(e). Respondent used the term ``adrenal extract'' for phentermine. See Gov. Exh. 1......
  • Schedules of Controlled Substances: Rescheduling of Hydrocodone Combination Products From Schedule III to Schedule II
    • United States
    • Federal Register August 22, 2014
    • August 22, 2014
    ...(codified at 21 U.S.C. 812(c)); initially codified at 21 CFR 308.13(e) (3) and (4) (36 FR 7776, April 24, 1971) (currently codified at 21 CFR 1308.13(e)(1) (iii) and (iv)).\3\ Any other hydrocodone single-entity products or combinations of hydrocodone with other substances outside the range......
  • Joe W. Morgan, D.O.; Decision and Order
    • United States
    • Federal Register October 08, 2013
    • October 8, 2013
    ...an anabolic steroid. 1-A Attorneys' Dictionary of Medicine A-6460. Anabolic steroids are Schedule III controlled substances pursuant to 21 CFR 1308.13(f) One of the most common things I might be asked to do other than testosterone might be an ADD drug or an ADHD, occasionally a sleeping pil......
  • Request a trial to view additional results
40 cases
  • United States v. Freeman, No. 19-4104
    • United States
    • United States Courts of Appeals. United States Court of Appeals (4th Circuit)
    • March 30, 2021
    ...Combination Products from Schedule III to Schedule II, 79 Fed. Reg. 49,661, 49,665 –66, 49,675 (Aug. 22, 2014) (codified at 21 C.F.R. § 1308.13(e)(1) ). Like other kinds of opioids, hydrocodone requires users to take progressively more pills in order to feel its effects and avoid painful wi......
  • John Doe, Inc. v. Drug Enforcement Admin., No. 06-1270.
    • United States
    • United States Courts of Appeals. United States Court of Appeals (District of Columbia)
    • April 27, 2007
    ...in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved product" to schedule III. 21 C.F.R. § 1308.13(g)(1) (emphasis added); 64 Fed. Reg. 35,928 (1999). DEA was careful to stress, however, that it was rescheduling dronabinol only "in a FDA a......
  • Wadlington v. Werlich, Case No. 17-cv-449-SMY
    • United States
    • United States District Courts. 7th Circuit. Southern District of Illinois
    • April 7, 2020
    ...to federal Schedule IV in 1973). Nor does not fall under the definitions of "marihuana" (21 U.S.C. § 802(16)(A)), "anabolic steroid" (21 C.F.R. § 1308.13(f), which lists anabolic steroids in federal Schedule III), or a "depressant or stimulant substance" (21 C.F.R.Page 17 §§ 1308.11(e) and ......
  • United States v. Akinyoyenu, Criminal Action No. 15-42 (JEB)
    • United States
    • U.S. District Court — District of Columbia
    • August 4, 2016
    ...811(a)(2); see id.§ 812(c) n.1. In this case, however, Akinyoyenu does not claim that she has done so for butalbital or Fioricet. See 21 C.F.R. § 1308.13(c)(3) (still listing "[a]ny substance which contains any quantity of a derivative of barbituric acid").Section 811(g) also provides other......
  • Request a trial to view additional results
4 firm's commentaries

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT